ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title |
Institution / Principal Investigator(s) |
Grant Type | Year | State |
|---|---|---|---|---|
| Role of PHF6 Mutations in Germline RUNX1 Deficiency Associated Hematopoietic Disorders | The Regents of the University of California San Francisco / Serine Avagyan, MD/PhD | RUNX1 Early Career Investigator Grants | 2021 | California |
| Circulating Tumor Biomarkers: New Paradigms for Management of Neuroblastoma | University of Chicago / Mark Applebaum, PhD | 'A' Award Grants | 2021 | Illinois |
| Hematopoietic stem cell function in familial platelet disorder therapy | University of Massachusetts Medical School / Lucio Castilla, PhD | Innovation Grants | 2021 | Massachusetts |
| Targeting EZHIP as a therapeutic strategy for infantile ependymomas | University of Wisconsin - Madison / Peter Lewis, PhD | Innovation Grants | 2021 | Wisconsin |
| Optimization of Drug Efflux and Brain Clearance to Improve CED of Targeted Therapy to H3K27M DMG | Mayo Clinic / David Daniels, MD/PhD | Reach Grants | 2021 | Minnesota |
| Activating Metabolic Pathways to Increase the Persistence of Leukemia Targeting T Cells | Children’s Hospital of Pittsburgh / Erica Braverman, MD | Young Investigator Grants | 2021 | Pennsylvania |
| Role of H3.3-G34R mutation in pediatric high-grade glioma | University of Texas M.D. Anderson Cancer Center / Jian Hu, PhD | Innovation Grants | 2021 | Texas |
| Choline Kinase and Alkylating Agent Resistance in Refractory Childhood Leukemias | Boston Children’s Hospital / Alejandro Gutierrez, MD | Innovation Grants | 2021 | Massachusetts |
| IND-Enabling Studies for WNTinib, a Novel Selective Therapeutic for CTNNB1 Mutant Hepatoblastomas | Icahn School of Medicine at Mount Sinai / Ernesto Guccione, PhD & Josep Llovet, MD & Arvin Dar, PhD | Reach Grants | 2021 | New York |
| A leukemia organoid platform for dissection and targeting of tumor-niche interactions | Columbia Institute for Cancer Genetics / Adolfo Ferrando, MD/PhD | Innovation Grants | 2021 | New York |